ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 652 • 2014 ACR/ARHP Annual Meeting

    Identification of Eat-2 As a Lupus Susceptibility Gene in New Zealand Black (NZB) Mice That Regulates Dendritic Cell Function

    Nafiseh Talaei1 and Joan E. Wither2, 1Genetics and Development, Toronto Western Research Institute, Toronto, ON, Canada, 21E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: We have previously shown that B6 mice with an introgressed homozygous NZB chromosome (c) 1 interval (70 to 100 cM) develop high titres of…
  • Abstract Number: 651 • 2014 ACR/ARHP Annual Meeting

    Inhibiting Tweak (TNF-like weak inducer of apoptosis) Signaling Improves Blood Brain Barrier Integrity and Protects from Neuronal Damage in Murine Neuropsychiatric Lupus

    Jing Wen1, Jessica Doerner1, Ariel Stock2, Jennifer Michaelson3, Linda Burkly3, Maria Gulinello2 and Chaim Putterman4, 1Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3Biogen Idec, Cambridge, MA, 4The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: While neuropsychiatric involvement in systemic lupus erythematosus (NPSLE) is relatively common and appears early, the underlying mechanisms are not fully understood. The disruption of…
  • Abstract Number: 650 • 2014 ACR/ARHP Annual Meeting

    Decreased Severity of Pristane Induced Lupus in miR155 Deficient Mice

    Harald Leiss1, Wilhelm Salzberger2, Irina Gessl1, Barbara Schwarzecker3, Nicolas Kozakowski4, Stephan Blüml1, Antonia Puchner1, Birgit Niederreiter3, Carl-Walter Steiner5, Josef Smolen3 and Georg H. Stummvoll2, 1Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Rheumatology, Medical University of Vienna, Vienna, Austria, 3Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 4Department of Pathology, Medical University of Vienna, Vienna, Austria, 5Division of Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose MicroRNAs (miRs) are an important class of regulators of gene expression that are associated with a variety of biological functions. Deregulation of endogenous miR155…
  • Abstract Number: 649 • 2014 ACR/ARHP Annual Meeting

    Enhance Translatability Using Multi-Modality Disease Evaluation Approach in Lupus Model

    Jie Zhang-Hoover1, Alan Byford1, Mark Zielstorff1, Robert Faltus2, Joseph Eckman2, Kimberly Bettano3, Gain Robinson3, Raquel Sevilla3, Bindu Bennet4, Lisa LaFranco-Scheuch4, Franklin Vives5, Michael Judo5, Gulesi Ayanoglu5, Weisheng Zhang3 and Milenko Cicmil2, 1Pharmacology, Merck Research Laboratories, Boston, MA, 2Merck Research Laboratories, Boston, MA, 3Imaging Group, Merck Research Laboratories, Boston, MA, 4SALAR-Pathology, Merck Research Laboratories, West Point, PA, 5Immunoassay Group, Merck Research Laboratories, Palo Alto, CA

    Background/Purpose: Rodent models mimic some aspects of human lupus disease manifestations in various tissues, such as kidney, skin, joint, and CNS. NZB/NZW F1 and MRL/lpr…
  • Abstract Number: 648 • 2014 ACR/ARHP Annual Meeting

    Influenza A (H1N1) Virus Infection Triggers Severe Pulmonary Inflammation in Lupus-Prone Mice Following Viral Clearance

    Samantha Slight-Webb1, Harini Bagavant1, Sherry Crowe1, Jourdan R. Anderson2 and Judith A. James3, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Each year, up to one fifth of the United States population is infected with influenza virus. Although mortality rates are low, hundreds of thousands…
  • Abstract Number: 647 • 2014 ACR/ARHP Annual Meeting

    Helminthes Derivative for Treating Lupus and Colitis in Mice Models

    Miri Blank1, Tomer Bashi1, Dana Ben-Ami Shor1, Mati Fridkin2, Iris Barshack3, Alexander Volkov4 and Yehuda Shoenfeld1, 1Zabludowicz Center for Autoimmune Diseases, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, 2Organic Chemistry, Weizmann Institute for Sciences, Rehovot, Israel, 3Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel, 4Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose:  In areas where helminthes infections are common, autoimmune diseases are rare. Treatment with ova from helminthes, improved clinical findings of inflammatory bowel disease and…
  • Abstract Number: 645 • 2014 ACR/ARHP Annual Meeting

    The Combination of Metformin and 2-Deoxy-D-Glucose Normalizes CD4 T Cell Metabolism and Functions, and Reverse Disease in Murine Models of Lupus

    Laurence Morel1, Yiming Yin2, Seung-Chul Choi2, Eric S. Sobel3 and Byron Croker2, 1Pathology/Immunology/Lab Medical, University of Florida, Gainesville, FL, 2University of Florida, Gainesville, FL, 3Medicine/Div of Rheumatology, University of Florida, Gainesville, FL

    Background/Purpose: Autoreactive CD4 T cells are key effectors in Systemic Lupus Erythematosus (SLE).  Cell metabolism is an important checkpoint for T cell activationand differentiation. Both…
  • Abstract Number: 644 • 2014 ACR/ARHP Annual Meeting

    HM-0523, a Novel Syk Inhibitor Blocks Glomerulonephritis and Extends Life Spans in Lupus Prone MRL/Lpr Mice

    Yu Cai1, Zhipeng Wu1, Ping Ren1, Xiaoming Dai1, Jianlin He1, Fang Yin1, Wei Deng1, Guangxiu Dai1, Weiguo Su1 and Xiong Li2, 1Hutchison Medipharma Limited, Shanghai, China, 2Building 4, 720 Cai Lun Road,, Hutchison Medipharma Limited, Shanghai, China

    Background/Purpose: Syk is a key mediator of signaling events downstream of a wide array of receptors important for immune functions, including the B cell receptor,…
  • Abstract Number: 643 • 2014 ACR/ARHP Annual Meeting

    The Effect of TNF Inhibition on the Autoreactive B Cell Repertoire in SLE Prone Mice

    Anne Davidson, Weiqing Huang and Ranjit Sahu, Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: TNF inhibitors are widely used for inflammatory diseases but often induce ANAs that sometimes progress to overt SLE. TNF deficient mice fail to generate…
  • Abstract Number: 642 • 2014 ACR/ARHP Annual Meeting

    Treatment with a Glycolipid Ameliorates Lupus Dermatitis and Expands Skin ãä T Cells That Promote the Migration of Langerhans Dendritic Cells

    Ram Raj Singh1,2,3, Anna Eriksson1, Darshan Randhawa1 and Miguel-Angel Gutierrez1, 1Autoimmunity and Tolerance Laboratory, Department of Medicine/Rheumatology, UCLA, Los Angeles, CA, 2Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, 3Interdepartmental Program in Molecular Toxicology, UCLA, Los Angeles, CA

    Background/Purpose: Self antigens are taken from tissues to local lymphoid organs to acquire ability to avoid self-reactivity.  This important immune function is accomplished by dendritic…
  • Abstract Number: 641 • 2014 ACR/ARHP Annual Meeting

    Peptidylarginine Deiminase Inhibition Mitigates NET Formation and Protects Against Kidney, Skin, and Vascular Disease in Lupus-Prone MRL/Lpr Mice

    Jason S. Knight1, Venkataraman Subramanian2, Alexander A. O'Dell1, Srilakshmi Yalavarthi1, Wenpu Zhao3, Carolyne K. Smith3, Jeffrey B. Hodgin4, Paul Thompson2 and Mariana J. Kaplan3, 1Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2The Scripps Research Institute, Jupiter, FL, 3Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4Department of Pathology, University of Michigan, Ann Arbor, MI

    Background/Purpose:  An imbalance between neutrophil extracellular trap (NET) production and NET degradation has been observed in systemic lupus erythematosus (SLE), potentially contributing to autoantigen externalization,…
  • Abstract Number: 640 • 2014 ACR/ARHP Annual Meeting

    A Peptide Mimic Inhibits the Cross Reaction of Anti-DNA Antibodies with Glomerular Antigens

    Yumin Xia1, Ertan Eryilmaz2, Rahul Pawar1, David Cowburn2 and Chaim Putterman3, 1Albert Einstein College of Medicine, Bronx, NY, 2Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, 3The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by high titers of multiple autoantibodies. Of those, anti-DNA antibodies play a key role in…
  • Abstract Number: 659 • 2014 ACR/ARHP Annual Meeting

    Breakdown of Tolerance at the Tissue Level in Systemic Autoimmunity: Role of Tissue-Resident Dendritic Cells

    Jennifer K. King1, Rachael Philips1, Anna Eriksson1 and Ram Raj Singh1,2,3,4, 1Autoimmunity and Tolerance Laboratory, Department of Medicine/Rheumatology, UCLA, Los Angeles, CA, 2Interdepartmental Program in Molecular Toxicology, UCLA, Los Angeles, CA, 3Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, 4Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA

    Background/Purpose Systemic autoimmune diseases such as lupus affect multiple organs including skin and kidneys, usually in a diverse fashion where only certain organs are affected…
  • Abstract Number: 646 • 2014 ACR/ARHP Annual Meeting

    ONO-4059 – a Highly Potent and Dual Oral Inhibitor of Bruton’s Tyrosine Kinase (Btk) and Tec Kinase: Improves Anti-Nuclear Antibodies–mediated SLE in Mice

    Yuko Ariza1, Toshio Yoshizawa1, Yoshiko Ueda1, Masayuki Murata1 and Kazuhito Kawabata2, 1Exploratory Research Laboratories 1, Ono Pharmaceutical Co., Ltd., Osaka, Japan, 2Discovery Research Laboratories 3, Ono Pharmaceutical Co., Ltd., Osaka, Japan

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a complex and heterogeneous autoimmune disease associated with the over production of high affinity autoantibodies, mainly raised against nuclear…
  • Abstract Number: 634 • 2014 ACR/ARHP Annual Meeting

    Characterization of CD4+ T Cell Response and Effects of Regulatory T Cells in Pristane Induced Lupus (PIL)

    Harald Leiss1, Barbara Schwarzecker2, Irina Gessl1, Antonia Puchner1, Birgit Niederreiter2, Carl-Walter Steiner3, Josef Smolen2 and Georg H. Stummvoll4, 1Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 3Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 4Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose CD4+ T cells and the Th1 and Th17 subsets in particular play a pivotal role in SLE. Regulatory T cells (Treg) are essential for…
  • « Previous Page
  • 1
  • …
  • 2188
  • 2189
  • 2190
  • 2191
  • 2192
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology